| Original language | English (US) |
|---|---|
| Pages (from-to) | 359-360 |
| Number of pages | 2 |
| Journal | JAMA cardiology |
| Volume | 6 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2021 |
Bibliographical note
Funding Information:Conflict of Interest Disclosures: Dr Legrand has received research support from the French Ministry of Health and SphingoTec, lecture fees from Baxter and Fresenius, and consulting fees from Novartis.
Funding Information:
Conflict of Interest Disclosures: Dr Madjid has received personal fees as a speaker and consultant to Sanofi Pasteur. Dr Solomon has received research grants from Alnylam Pharmaceuticals, Amgen, AstraZeneca, Bellerophon Therapeutics, Bayer, Bristol Myers Squibb, Celladon, Cytokinetics, Eidos Therapeutics, Gilead Sciences, GlaxoSmithKline, Ionis Pharmaceuticals, Lone Star Heart and Vascular Center, Mesoblast, MyoKardia, Neurotronik, National Institutes of Health, National Heart, Lung, and Blood Institute, Novartis, Sanofi Pasteur, and Theracos and personal fees for consulting from Akros, Alnylam Pharmaceuticals, Amgen, Arena Pharmaceuticals, AstraZeneca, Bayer, Bristol Myers Squibb, Cardior Pharmaceuticals, Cardurion Pharmaceuticals, Corvia Medical, Cytokinetics, Daiichi Sankyo, Gilead Sciences, GlaxoSmithKline, Ironwood Pharmaceuticals, Merck, MyoKardia, Novartis, Roche, Sanofi Pasteur, Takeda, Theracos, Quantum Genetics, AOBiome, Janssen, Cardiac Dimensions, Tenaya Therapeutics, DiNAQOR, Tremeau Pharmaceuticals, CellProthera, and Moderna. Dr Vardeny has received research support from the National Institutes of Health and personal fees for consulting from Sanofi Pasteur.
